This study confirmed previous known patterns, including that ER-/PR- breast cancers are more often seen in BRCA1 PV carriers, in younger females, whereas ER + /PR + breast cancers are more often seen in BRCA2 PV carriers [10]. Here, ESR1 is linked to breast carcinoma.